Abstract
Hypokinetic dysarthria in Parkinson’s disease (PD) can be characterized by monotony of pitch and loudness, reduced stress, variable rate, imprecise consonants, and a breathy and harsh voice. Using acoustic analysis, we studied the effects of high-frequency repetitive transcranial magnetic stimulation (rTMS) applied over the primary orofacial sensorimotor area (SM1) and the left dorsolateral prefrontal cortex (DLPFC) on motor aspects of voiced speech in PD. Twelve non-depressed and non-demented men with PD (mean age 64.58 ± 8.04 years, mean PD duration 10.75 ± 7.48 years) and 21 healthy age-matched men (a control group, mean age 64 ± 8.55 years) participated in the speech study. The PD patients underwent two sessions of 10 Hz rTMS over the dominant hemisphere with 2,250 stimuli/day in a random order: (1) over the SM1; (2) over the left DLPFC in the “on” motor state. Speech examination comprised the perceptual rating of global speech performance and an acoustic analysis based upon a standardized speech task. The Mann–Whitney U test was used to compare acoustic speech variables between controls and PD patients. The Wilcoxon test was used to compare data prior to and after each stimulation in the PD group. rTMS applied over the left SM1 was associated with a significant increase in harmonic-to-noise ratio and net speech rate in the sentence tasks. With respect to the vowel task results, increased median values and range of Teager-Kaiser energy operator, increased vowel space area, and significant jitter decrease were observed after the left SM1 stimulation. rTMS over the left DLPFC did not induce any significant effects. The positive results of acoustic analysis were not reflected in a subjective rating of speech performance quality as assessed by a speech therapist. Our pilot results indicate that one session of rTMS applied over the SM1 may lead to measurable improvement in voice quality and intensity and an increase in speech rate and tongue movements. Nevertheless, these changes were not accompanied by changes in a perceptual evaluation of speech performance by a speech therapist. Future placebo-controlled studies in larger patient cohorts should verify if rTMS would be clinically useful for treating hypokinetic dysarthria in PD.
Similar content being viewed by others
References
Barrett J, Della-Maggiore V, Chouinard PA, Paus T (2004) Mechanisms of action underlying the effect of repetitive transcranial magnetic stimulation on mood: behavioral and brain imaging studies. Neuropharmacology 29:1172–1189
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571
Beck AT, Steer RA, Brown GK (1996) Manual for the beck depression inventory-2. Psychological Corporation, San Antonio, TX
Boersma P, Weenink D (2012) Praat: doing phonetics by computer (Version 5.3.23) http://www.praat.org/. Accessed 27 August 2012
Boggio PS, Fregni F, Bermpohl F, Mansur CG, Rosa M, Rumi DO, Barbosa ER, Odebrecht Rosa M, Pascual-Leone A, Rigonatti SP, Marcolin MA, Araujo Silva MT (2005) Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson’s disease and concurrent depression. Mov Disord 20(9):1178–1184
Calzavara R, Mailly P, Haber SN (2007) Relationship between the corticostriatal terminals from areas 9 and 46, and those from area 8A, dorsal and rostral premotor cortex and area 24c: an anatomical substrate for cognition to action. Eur J Neurosci 26(7):2005–2024
Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, Ondo W, Abe K, MacPhee G, MacMahon D, Barone P, Rabey M, Forbes A, Breen K, Tluk S, Naidu Y, Olanow W, Williams AJ, Thomas S, Rye D, Tsuboi Y, Hand A, Schapira AHV (2007) The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: results from an International Pilot Study. Mov Disord 22(13):1901–1911
Cho SS, Strafella AP (2009) rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex. PLoS One 4(8):e6725
D'Alatri L, Paludetti G, Contarino FM, Galla S, Marchese MR, Bentivoglio AR (2008) Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment. J Voice 22(3):365–372
Daniels N, Oates J, Phyland D, Feiglin A, Hughes A (1996) Vocal characteristics and response to levodopa in Parkinson’s disease. Mov Disord 11(Suppl. 1):117
De Letter M, Santens P, Borsel JV (2005) The effects of levodopa on world intelligibility in Parkinson’s disease. J Commun Disord 38(3):187–196
Dell’osso B, Camuri G, Castellano F, Vecchi V, Benedetti M, Bortolussi S, Altamura AC (2011) Meta-review of metanalytic studies with repetitive transcranial magnetic stimulation (rTMS) for the treatment of major depression. Clin Pract Epidemiol Ment Health 7:167–177
Dias AE, Barbosa ER, Coracini KK, Maia FF, Marcolin MA, Fregni F (2006) Effects of repetitive transcranial magnetic stimulation on voice and speech in Parkinson’s disease. Acta Neurol Scand 113:92–99
Dimitriadis D, Potamianos A, Maragos P (2009) A comparison of the squared energy and Teager-Kaiser operators for short-term energy estimation in additive noise. IEEE T Signal Process 57:2569–2581
Elahi B, Elahi B, Chen R (2009) Effect of transcranial magnetic stimulation on Parkinson motor function: systematic review of controlled clinical trials. Mov Disord 24(3):357–363
Fahn S, Elton RL, UPDRS Development Committee (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson’s disease. Macmillan, Florham Park, pp 153–163
Folstein MF, Folstein SE, McHugh PR (1975) “Mini mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198
Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn SD (2000) Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord 6:165–170
Goberman AM, Elmer LW (2005) Acoustic analysis of clear versus conversational speech in individuals with Parkinson disease. J Commun Disord 38:215–230
Guse B, Falkai P, Wobrock T (2010) Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: a systematic review. J Neural Transm 117(1):105–122
Hartelius L, Svantensson P, Hedlund A, Holmberg B, Revesz D, Thorlin T (2010) Short-term effects of repetitive transcranial magnetic stimulation on speech and voice in individuals with Parkinson’s disease. Folia Phoniatr Logop 62:104–109
Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Goelbe L, Huber S, Koller W, Olanov C, Shoulson I, Stern M, Tanner C, W. Weiner W, and Parkinson Study Group (1990) Variable expression of Parkinson’s disease: a baseline analysis of the DAT ATOP cohort. Neurology 40:1529–1534
Larson KK, Ramig LO, Scherer RC (1994) Acoustic and glottographic voice analysis during drug-related fluctuations in Parkinson’s disease. J Med Speech Lang Pathol 2:227–239
Lee JY, Kim JW, Lee WY, Kim JM, Ahn TB, Kim HJ, Cho J, Jeon BS (2010) Daily dose of dopaminergic medications in Parkinson disease: clinical correlates and a posteriori equation. Neurology Asia 15(2):137–143
Leh SE, Petrides M, Strafella AP (2010) The neural circuitry of executive function in healthy subjects and Parkinson’s disease. Neuropsychopharmacol Rev 35:70–85
Limousin P, Krack P, Pollack P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL (1998) Stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 339:1105–1111
Michaelis D, Gramss T, Strube HW (1997) Glottal-to-noise excitation ratio—a new measure for describing pathological voices. Acta Acustica 83:700–706
Murdoch BE (1998) Dysarthria: a physiological approach to assessment and treatment. Nelson Thornes, Cheltenham
Murdoch BE, Ng ML, Barwood CHS (2012) Treatment of articulatory dysfunction in Parkinson’s disease using repetitive transcranial magnetic stimulation. Eur J Neurol 19(2):340–347
Narayana S, Fox PT, Zhang W, Franclin C, Robin DA, Vogel D, Ramig LO (2010) Neural correlates of efficacy of voice therapy in Parkinson’s disease identified by performance-correlation analysis. Hum Brain Mapp 31:222–236
Pal E, Nagy F, Aschermann Z, Balazs E, Kovacs N (2010) The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson’s disease: a randomized, double-blind, placebo-controlled study. Mov Disord 25(14):2311–2317
Parent A (1990) Extrinsic connections of the basal ganglia. Trends Neurosci 13:254–258
Parent A, Hazrati LN (1995) Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev 20(1):91–127
Petrides M, Pandya DN (1999) Dorsolateral prefrontal cortex: comparative cytoarchitectonic analysis in the human and the macaque brain and corticocortical connection patterns. Eur J Neurosci 11:1011–1036
Petrides M, Alivisatos B, Meyer E, Evans AC (1993) Functional activation of the human frontal cortex during the performance of verbal working memory task. Proc Natl Acad Sci USA 90:878–882
Pinto S, Ozsancak C, Tripoliti E, Thobois S, Limousin-Dowsey P, Auzou P (2004) Treatments for dysarthria in Parkinson’s disease. Lancet Neurol 3:547–556
Poluha PC, Teulings HL, Brookshire RH (1998) Handwriting and speech changes across the levodopa cycle in Parkinson’s disease. Acta Psychologica (Amst.) 100(1–2):71–84
Ramig LO, Sapir S, Countryman S, Pawlas AA, O’Brien C, Hoehn M, Thompson LL (2001) Intensive voice treatment (LSVT®) for patients with Parkinson’s disease: a 2 year follow up. J Neurol Neurosurg Psychiatry 71:493–498
Ramig LO, Fox C, Sapir S (2008) Speech treatment for Parkinson’s disease. Expert Rev Neurother 8(2):297–309
Rektorova I, Megova S, Bares M, Rektor I (2005) Cognitive functioning after repetitive transcranial magnetic stimulation in patients with cerebrovascular disease without dementia: a pilot study of seven patients. J Neurol Sci 229–230:157–161
Rektorova I, Barrett J, Mikl M, Rektor I, Paus T (2007a) Functional abnormalities in the primary orofacial sensorimotor cortex during speech in Parkinson’s disease. Mov Disord 22(14):2043–2051
Rektorova I, Sedlackova S, Megova S, Hlubocky A, Rektor I (2007b) Repetitive transcranial magnetic stimulation for freezing of gait (FOG) in Parkinson’s disease. Mov Disord 22:1518–1519
Roubickova J, Hedanek J, Stranik A (2011) Dysarthric profile. Galen, Praha
Rousseaux M, Krystkowiak P, Kozlowski O, Ozsancak C, Blond S, Destee A (2004) Effects of subthalamic nucleus stimulation on parkinsonian dysarthria and speech intelligibility. J Neurol 251:327–334
Rusz J, Cmejla R, Ruzickova H, Klempir J, Majerova V, Picmausova J, Roth J, Ruzicka E (2012) Evaluation of speech impairment in early stages of Parkinson’s disease: a prospective study with the role of pharmacotherapy. J Neural Transm. doi:10.1007/s00702-012-0853-4
Sapir S, Ramig LO, Spielman JL, Fox C (2010) Formant centralization ratio (FCR): a proposal for a new acoustic measure of dysarthric speech. J Speech Lang Hear Res 53(1):114. doi:10.1044/1092-4388(2009/08-0184
Sedlácková S, Rektorová I, Srovnalová H, Rektor I (2009) Effect of high frequency repetitive transcranial magnetic stimulation on reaction time, clinical features and cognitive functions in patients with Parkinson’s disease. J Neural Transm 116(9):1093–1101
Siebner HR, Rothwell J (2003) Transcranial magnetic stimulation: new insights into representational cortical plasticity. Exp Brain Res 148(1):1–16
Skodda S, Visser W, Schlegel U (2010) Short- and long-term dopaminergic effects on dysarthria in early Parkinson’s disease. J Neural Transm 117:197–205
Solomon NP, Hixon TJ (1993) Speech breathing in Parkinson’s disease. J Speech Hear Res 36:294–310
Stiasny-Kolster K, Mayer G, Schäfer S, Möller JC, Heinzel-Gutenbrunner M, Oertel WH (2007) The REM sleep behavior disorder screening questionnaire—A new diagnostic instrument. Mov Disord 22(16):2386–2393
Strafella AP, Paus T, Barrett J, Dagher A (2001) Repetitive transcranial magnetic stimulation of the human prefrontal cortex induced dopamine release in the caudate nucleus. J Neurosci 21:RC157
Ward CD, Gibb WR (1990) Research diagnostic criteria for Parkinson’s disease. Adv Neurol 53:245–249
Acknowledgments
This work was supported by project NT13499 (Speech, its impairment and cognitive performance in Parkinson’s disease), project SIX (CZ.1.05/2.1.00/03.0072), project GACR 102/12/1104, and project “CEITEC, Central European Institute of Technology”: (CZ.1.05/1.1.00/02.0068) from the European Regional Development Fund.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eliasova, I., Mekyska, J., Kostalova, M. et al. Acoustic evaluation of short-term effects of repetitive transcranial magnetic stimulation on motor aspects of speech in Parkinson’s disease. J Neural Transm 120, 597–605 (2013). https://doi.org/10.1007/s00702-012-0953-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-012-0953-1